Related Experiment Video
Updated: Jul 3, 2025

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Activated fibroblasts drive cellular interactions in end-stage pediatric hypertrophic cardiomyopathy
Hanna J Tadros1, Diwakar Turaga2,3, Yi Zhao4
1Department of Pediatrics, Section of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Insights
Pediatric end-stage hypertrophic cardiomyopathy (HCM) shows distinct cellular changes, including stressed cardiomyocytes and increased fibrosis. This study offers the first single-nucleus analysis of pediatric HCM.
Area of Science:
- Cardiovascular Biology
- Pediatric Cardiology
- Molecular Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a rare, debilitating pediatric diagnosis.
- End-stage HCM necessitates heart transplantation.
- Understanding pediatric HCM's cellular basis is crucial.
Approach:
- Single-nucleus RNA sequencing (snRNA-seq) was performed on pediatric HCM and control myocardium.
- Cellular processes in cardiomyocytes, fibroblasts, endothelial cells, and myeloid cells were analyzed.
- Comparison between pediatric HCM and control samples provided insights.
Key Points:
- Pediatric HCM cardiomyocytes showed "stressed" myocardium signatures and cardiac hypertrophy pathways.
- Cardiac fibroblasts displayed heightened activation and fibrosis-associated processes, exceeding adult counterparts.
- Tissue-resident macrophages were depleted, and endothelial cells showed increased vascular remodeling.
Conclusions:
- This study presents the first single-nucleus analysis of end-stage pediatric HCM.
- Distinct cellular and molecular alterations characterize pediatric HCM.
- Findings highlight novel therapeutic targets for pediatric HCM.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a relatively rare but debilitating diagnosis in the pediatric population and patients with end-stage HCM require heart transplantation. In this study, we performed single-nucleus RNA sequencing on pediatric HCM and control myocardium. We identified distinct underling cellular processes in pediatric, end-stage HCM in cardiomyocytes, fibroblasts, endothelial cells, and myeloid cells, compared to controls. Pediatric HCM was enriched in cardiomyocytes exhibiting "stressed" myocardium gene signatures and underlying pathways associated with cardiac hypertrophy. Cardiac fibroblasts exhibited clear activation signatures and heightened downstream processes associated with fibrosis, more so than adult counterparts. There was notable depletion of tissue-resident macrophages, and increased vascular remodeling in endothelial cells. Our analysis provides the first single nuclei analysis focused on end-stage pediatric HCM.
Related Concept Videos
Introduction to Fibroblasts
Pathophysiology of Heart Failure
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...

